Results 161 to 170 of about 104,745 (290)

Immunotherapie genique des cancers ovariens : etude des interactions entre p53 et les oncosuppresseurs brca1, brca2 et atm (doctorat : biologie moleculaire)

, 2000
Bénédicte Aunoble
openalex   +2 more sources

Pleural Metastasis From Male Breast Cancer: A Case Report

Diagnostic Cytopathology, Volume 54, Issue 2, Page E36-E39, February 2026.
ABSTRACT Male breast cancer (MBC) is a rare disease accounting for less than 1% of breast cancers and for 0.11% of all male malignancies. Despite the fact that the epidemiologic, clinical, and therapeutic literature regarding female breast cancer is well documented, little is known about the features of male breast cancer.
Patrizia Straccia, Esther Diana Rossi
wiley   +1 more source

Double Heterozygotes for the Ashkenazi Founder Mutations in BRCA1 and BRCA2 Genes [PDF]

, 1998
Eitan Friedman, Revital Bruchim, Anna Kruglikova, S Risel, Ephrat Levy‐Lahad, David Halle, Elchanan Bar-On, Ruth Gershoni‐Baruch, E. Dagan, Ilana Kepten, Tamar Peretz, Israela Lerer, Naomi Wienberg, Asher Shushan, Dvorah Abeliovich   +14 more
openalex   +1 more source

Generation of functional noncanonical donor splice sites by +2T variants in breast cancer susceptibility genes: impact on clinical interpretation

The Journal of Pathology, Volume 268, Issue 2, Page 150-163, February 2026.
Abstract Splicing dysregulation is a relevant mechanism of pathogenicity for variants in disease susceptibility genes. Variants affecting the critical intronic +1 and +2 GT nucleotides of the 5’ splice sites (5'ss) are generally strong indicators of pathogenicity.
Inés Llinares‐Burguet, Lara Sanoguera‐Miralles, Elena Bueno‐Martínez, Alicia García‐Álvarez, Alberto Valenzuela‐Palomo, Pedro Pérez‐Segura, Miguel de la Hoya, Eladio A Velasco‐Sampedro   +7 more
wiley   +1 more source

LBA-08 SCREENING OF BRCA2 MUTATED MEN FOR DETECTION OF PROSTATE CANCER: PRELIMINARY RESULTS FROM A NATIONAL HIGH VOLUME CANCER CENTRE [PDF]

, 2019
Nicolò Maria Buffi, Alberto Saita, Giorgio Guazzoni, Giovanni Lughezzani, Paolo Casale, Rodolfo Hurle, Monica Zuradelli, Armando Santoro, Massimo Lazzeri   +8 more
openalex   +1 more source

The Arabidopsis Mutant of the Small Intrinsically Disordered Protein DSS1(V) Exhibits Increased Sensitivity to Drought Stress

Plant Direct, Volume 10, Issue 2, February 2026.
ABSTRACT Drought has emerged as one of the most severe and widespread environmental stresses affecting plants. Crops exposed to varying levels of drought, ranging from moderate to severe, often experience notable declines in yield or reduced harvest quality.
Ivana Nikolic, Maja Sabljic, Mira Milisavljevic, Ivan Radin, Gordana Timotijevic   +4 more
wiley   +1 more source

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients

Сибирский онкологический журнал, 2016
BRCA1 and BRCA2 may contribute in pancreatic cancer (PC) risk, however the selection criteria for BRCA1 testing are poorly defined. The analysis of Russian founder mutation BRCA1 5382insC in 150 PC patients identified 2 carriers.
A. A. Kashintsev, G. A. Yanus, N. Yu. Kokhanenko, V. M. Moiseenko, M. D. Hanevich, L. D. Roman, A. G. Ievleva, A. P. Sokolenko, E. N. Suspitsin, A. I. Budovskiy, A. V. Togo, N. M. Volkov, R. V. Fadeev, M. S. Dinikin, A. K. Ivanova, K. G. Shostko, E. N. Imyanitov   +16 more
doaj  

Twenty years of BRCA1 and BRCA2 molecular analysis at MMCI : current developments for the classification of variants [PDF]

, 2019
Claes, Kathleen, Foretova, L, Hazova, J, Machackova, E, Mikova, M, Navratilova, M, Stahlova Hrabincova, E, Svoboda, M, Trbusek, M, Vasickova, P   +9 more
core   +2 more sources

A Comprehensive and Accessible Model for Co-Segregation Analysis in BRCA1, BRCA2 , and PALB2 Variant Classification [PDF]

Setareh Moghadasi, Ramin Monajemi, Merel E. Braspenning, Maaike P.G. Vreeswijk, Mar Rodriguez Girondo   +4 more
openalex   +1 more source

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer

The Prostate, Volume 86, Issue 3, Page 338-348, February 15, 2026.
ABSTRACT Objective To evaluate the value of circulating free DNA (cfDNA) in prostate cancer (PCa) by cfDNA assay and analysis of plasma and urinary cfDNA fragmentation to determine the usefulness of this parameter for risk staging and tumor progression monitoring.
Marta Victoria Lorenzo‐Sánchez, José Miguel Giménez‐Bachs, María Granada Picazo‐Martínez, María José Donate‐Moreno, Carlos Martínez‐Sánchiz, María Amalia Tárraga‐Honrubia, Sonsoles Navarro‐Jiménez, Óscar Legido‐Gómez, Antonio Santiago Salinas‐Sánchez   +8 more
wiley   +1 more source